EUVIMEDEUVIMED entdecken
Crossref

Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss

Fei Gu, Kun Zeng, Xianglong Lan, Yaozu He, Feng Li iD, Xiaoping Tang, Fengyu Hu, Linghua Li iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Fei Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Guangzhou Medical Research Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical …. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis B Surface Antigens, Coinfection, Hepatitis B virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Medical Key Discipline Program of Guangzhou-Viral Infectious Diseases (2021-2023), Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Functional cure of hepatitis B virus (HBV) is an optimal treatment goal for chronic hepatitis B, with the loss of hepatitis B surface antigen (HBsAg) being a crucial indicator. However, the adequacy of HBsAg loss for evaluating functional cure of HBV in patients co‐infected with HBV/human immunodeficiency virus (HIV) remains controversial. In this study, we measured HBV pregenomic RNA (pgRNA), a potential biomarker that correlates with covalently closed circular DNA, in the frozen plasma of 98 patients with HBsAg loss from a large HIV/HBV co‐infection cohort in Guangzhou, China. HBV pgRNA was still detected in 43.9% (44/98) of the patients, suggesting active HBV replication in individuals with HBsAg loss. Our observations imply that HBsAg loss may not be a reliable predictor of HBV functional cure in cases of HIV/HBV co‐infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHepatitis B Surface AntigensCoinfectionHepatitis B virusRNA, ViralBiomarkersHepatitis B, ChronicHumansMaleFemaleAdultMiddle AgedChinaDNA, ViralVirus ReplicationCohort StudiesRNA

Stichwörter der Autor:innen

HBV functional cureHBV pregenomic RNA (pgRNA)HBsAg lossHIV/HBV co‐infectionantiretroviral therapy (ART)

Substanzen

Hepatitis B Surface AntigensRNA, ViralBiomarkersDNA, ViralpgRNARNA

Autor:innen und Institutionen

  • Department of Infectious Disease, Guangzhou Medical Research Institute of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Guangzhou Medical Research Institute of Infectious Diseases, Institution of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.

ORCID-Profile: Feng Li, Linghua Li

Förderung

  • Medical Key Discipline Program of Guangzhou-Viral Infectious Diseases (2021-2023)
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Gu, F., Zeng, K., Lan, X., He, Y., Li, F., Tang, X., Hu, F., & Li, L. (2024). Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss. Journal of Medical Virology. https://doi.org/10.1002/jmv.29762

Vancouver

Gu F, Zeng K, Lan X, He Y, Li F, Tang X, et al. Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss. Journal of Medical Virology. 2024. doi:10.1002/jmv.29762

BibTeX
@article{Gu2024,
  author = {Gu, Fei and Zeng, Kun and Lan, Xianglong and He, Yaozu and Li, Feng and Tang, Xiaoping and Hu, Fengyu and Li, Linghua},
  title = {Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29762}
}
Kostenlos starten →